Market Insights Health Medical Technology Medical Devices

Diabetes Care Devices - EU-27

EU-27

Revenue in the Diabetes Care Devices market market in the EU-27 is projected to reach US$4.72bn in 2024.
Revenue is anticipated to exhibit an annual growth rate (CAGR 2024-2029) of 11.79%, leading to a market volume of US$8.24bn by 2029.
In a global context, the majority of revenue is expected to be generated the United States, with a figure of US$11,710.00m in 2024.
The EU-27 market for diabetes care devices is increasingly prioritizing innovative digital solutions to enhance patient engagement and self-management strategies.

Key regions: Netherlands, Japan, France, Italy, China

Market

Region

Region comparison

Currency

Analyst Opinion

The Diabetes Care Devices Market in the EU-27 is witnessing considerable growth, fueled by the rising prevalence of diabetes, advancements in technology, and increasing awareness of diabetes management among patients and healthcare professionals.

Customer preferences: Consumers in the EU-27 are increasingly favoring integrated diabetes care devices that offer seamless connectivity with smartphones and health apps, reflecting a demand for personalized and data-driven management solutions. There is a growing preference for user-friendly devices that cater to diverse lifestyles, particularly among younger demographics who prioritize convenience and real-time feedback. Additionally, cultural shifts towards proactive health management are driving interest in educational resources and community support platforms that empower patients in their diabetes journey.

Trends in the market: In the EU-27, the Diabetes Care Devices Market is experiencing a notable shift towards smart, integrated devices that emphasize connectivity with smartphones and health applications. This trend reflects a broader consumer demand for personalized, data-driven management solutions that enhance patient engagement. As younger generations prioritize convenience and real-time feedback, manufacturers are adapting to create user-friendly products that fit diverse lifestyles. Furthermore, the rising interest in educational resources and community support platforms signifies a cultural shift towards proactive health management, impacting industry stakeholders by encouraging innovation and collaboration in diabetes care solutions.

Local special circumstances: In the EU-27, the Diabetes Care Devices Market is shaped by stringent regulatory frameworks that prioritize patient safety and efficacy, leading to rigorous testing and approval processes for new technologies. Additionally, diverse healthcare systems across member states create varying levels of access to diabetes care devices, influencing market penetration and adoption rates. Cultural emphasis on preventive healthcare and self-management further drives demand for innovative solutions, with a growing acceptance of telemedicine and digital health tools enhancing patient engagement and adherence to treatment regimens.

Underlying macroeconomic factors: The Diabetes Care Devices Market within the EU-27 is significantly influenced by macroeconomic factors including the overall health of national economies, investment in healthcare infrastructure, and fiscal policies aimed at promoting innovation. Economic stability and growth encourage government and private sector investments in diabetes technologies, enhancing research and development. Furthermore, the rising burden of diabetes alongside an increasing aging population underscores the urgent need for effective diabetes management solutions. Additionally, fluctuating healthcare budgets and varying public reimbursement policies across member states impact the affordability and accessibility of advanced diabetes care devices, ultimately shaping market dynamics.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.